ASCO 2023: Oncolytic Viruses Post-Conference Report

With over 5000 abstracts presented at ASCO 2023, the Beacon team have been dedicated to narrowing down the relevant abstracts vital for your research endeavors. We have identified 41 oncolytic viruses-relevant abstracts including 37 clinical and 4 preclinical . This is a 31% increase in the number of oncolytic viruses-relevant abstracts presented in 2022. Download the post-conference below to view the abstract analysis and summary.

ASCO 2023: Oncolytic Viruses Abstract Highlights

This post-conference report offers a complete guide to all the oncolytic viruses topics and provides you with an abstract analysis split into data type, viral family, and clinical abstract properties. Also the clinical, trial outline, and preclinical abstract summaries.

You May Also Be Interested In…

Learn More About Oncolytic Viruses

What is Beacon Oncolytic Viruses?
  • The Most Comprehensive Way to Search the Oncolytic Viruses Drug Development Landscape: Unique search ontologies based on Oncolytic Viruses drug and trial characteristics
  • Market Leading Approach to Oncolytic Viruses Preclinical & Clinical Data Curation: Manual curation of key Oncolytic Viruses research and development data points by Oncolytic Viruses research scientists
  • Seamlessly Integrate Commercial & Scientific Data all in One Place: Search Oncolytic Viruses company and deal data based on their pipeline and technologies.
  • Unrivalled Granularity in Reports & Analysis: Our search ontology and technology indexing enable comprehensive analysis not seen elsewhere.
Learn More About Beacon Oncolytic Viruses Request Demo

What is Beacon?

Beacon is the essential intelligence platform for R&D decision-makers working in pharma and biotech, offering unique technology and drug datasets for complex therapeutics and disease areas.

Our market-defining proprietary ontologies, manual data curation, and accurate and comprehensive life science data, provide our customers with unparalleled visibility of the drug, trial and commercial landscape.

This is why 24 of the top 25 pharmaceutical companies trust Beacon to power their critical pipeline, competitive, and commercial decisions.

We’d welcome the opportunity to show you how Beacon can transform your data strategy. Book your personalized demonstration today!

Request Demonstration

Menu
Search Icon
Close Icon
Search